Monthly Communication Report

Corporation:	AstraZeneca Canada Inc.
Associated registration:	957438-15042-63
Communication date:	2025-12-04
Posted date:	2026-01-15

Designated Public Office Holders who participated in the communication:	Hosai Zurmati Halim, Senior Policy Advisor Office of the President of the Treasury Board of Canada, Treasury Board Of Canada Secretariat (TBS) Elizabeth  Wong, Senior Policy Advisor Office of the President of the Treasury Board of Canada, Treasury Board Of Canada Secretariat (TBS)
List of Details Subject matter Detail Economic Development, Federal-Provincial Relations, Health, Industry, Intellectual Property, Research and Development Policies and frameworks to accelerate access to innovative medicines post-Health Canada approval, including efforts to reduce time-to-reimbursement and streamline federal/provincial listing processes Budget, Economic Development, Federal-Provincial Relations, Foreign Affairs, Government Procurement, Health, Industry, International Trade, Research and Development Policy measures to ensure security of drug supply in Canada and preserve Canada’s attractiveness for biopharmaceutical launches, including in response to foreign pricing regulations
Responsible Officer who filed this communication report:	Gaby Bourbara
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.